Sweden Drug And Gene Delivery Devices Market Size & Outlook

The drug and gene delivery devices market in Sweden is expected to reach a projected revenue of US$ 17.2 million by 2030. A compound annual growth rate of 8.1% is expected of Sweden drug and gene delivery devices market from 2025 to 2030.
Revenue, 2024 (US$M)
$10.8
Forecast, 2030 (US$M)
$17.2
CAGR, 2025 - 2030
8.1%
Report Coverage
Sweden

Sweden drug and gene delivery devices market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Sweden drug and gene delivery devices market, 2018-2030 (US$M)

Related Markets

Sweden drug and gene delivery devices market highlights

  • The Sweden drug and gene delivery devices market generated a revenue of USD 10.8 million in 2024 and is expected to reach USD 17.2 million by 2030.
  • The Sweden market is expected to grow at a CAGR of 8.1% from 2025 to 2030.
  • In terms of segment, oral was the largest revenue generating route of administration in 2024.
  • Injectable is the most lucrative route of administration segment registering the fastest growth during the forecast period.

Drug and gene delivery devices market data book summary

Market revenue in 2024USD 10.8 million
Market revenue in 2030USD 17.2 million
Growth rate8.1% (CAGR from 2025 to 2030)
Largest segmentOral
Fastest growing segmentInjectable
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Key market players worldwidePfizer Inc, Roche Holding AG, Johnson & Johnson, Novartis AG ADR, Bayer AG, Becton Dickinson & Co

Other key industry trends

  • In terms of revenue, Sweden accounted for 1.5% of the global drug and gene delivery devices market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK drug and gene delivery devices market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 26.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug And Gene Delivery Devices Market Scope

Drug and gene delivery devices market segmentation & scope

Drug And Gene Delivery Devices Market Companies

Name Profile # Employees HQ Website

Sweden drug and gene delivery devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug and gene delivery devices market will help companies and investors design strategic landscapes.


Oral was the largest segment with a revenue share of 56.48% in 2024. Horizon Databook has segmented the Sweden drug and gene delivery devices market based on oral, inhalation, transdermal, injectable, ocular, nasal, topical covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Sweden drug and gene delivery devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden drug and gene delivery devices market databook

  • Our clientele includes a mix of drug and gene delivery devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden drug and gene delivery devices market, including forecasts for subscribers. This country databook contains high-level insights into Sweden drug and gene delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden drug gene delivery devices market size, by route of administration, 2018-2030 (US$M)

Sweden Drug And Gene Delivery Devices Market Share, 2024 & 2030 (US$M)

Sweden drug gene delivery devices market size, by route of administration, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more